Abstract
OPINION article Front. Pharmacol., 17 February 2014Sec. Drugs Outcomes Research and Policies https://doi.org/10.3389/fphar.2014.00014
Highlights
In this issue Lenoir-Wijnkoop et al (2014) show that an affordable and widely available fermented dairy drink containing a known and well-documented probiotic could lead to health care system cost savings
Probiotics in iatrogenic bowel irregularity be cost effective, as recently shown in a meta-analysis based on all available data (Daneman, 2013)
When classified as functional foods, probiotic effects pertaining to human health, consist of claims subject to evaluation by regulatory institutes such as the European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA)
Summary
In this issue Lenoir-Wijnkoop et al (2014) show that an affordable and widely available fermented dairy drink containing a known and well-documented probiotic could lead to health care system cost savings. Probiotics in iatrogenic bowel irregularity be cost effective, as recently shown in a meta-analysis based on all available data (Daneman, 2013). Hospital dieticians and cooks could use the data of the LenoirWijnkoop study in conjunction with high GOS and FOS foods for synergy (known as synbiotics) and enhance the calculated beneficial effects by minor dietary interventions at marginal extra cost.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
